Exelon Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


1.1 Alzheimer’s Disease

Exelon Patch (rivastigmine transdermal system) is indicated for the treatment of mild to moderate dementia of the Alzheimer’s type.

1.2 Parkinson’s Disease Dementia

Exelon Patch (rivastigmine transdermal system) is indicated for the treatment of mild to moderate dementia associated with Parkinson’s disease.

The dementia of Parkinson’s disease is purportedly characterized by impairments in executive function, memory retrieval, and attention in patients with an established diagnosis of Parkinson’s disease. The diagnosis of dementia of Parkinson’s disease can be made reliably in patients in whom a progressive dementia syndrome occurs (without the necessity to document the specific deficits described above) at least 2 years after a diagnosis of Parkinson’s disease has been made, and in whom other causes of dementia have been ruled out.


There is currently no drug history available for this drug.

Other Information

Exelon Patch (rivastigmine transdermal system) is a reversible cholinesterase inhibitor and is known chemically as (S)- 3-[1-(dimethylamino) ethyl]phenyl ethylmethylcarbamate. It has an empirical formula of C14H22N2O2 as the base and a molecular weight of 250.34 (as the base). Rivastigmine is a viscous, clear, and colorless to yellow to very slightly brown liquid that is sparingly soluble in water and very soluble in ethanol, acetonitrile, n-octanol and ethyl acetate.

The distribution coefficient at 37°C in n-octanol/phosphate buffer solution pH 7 is 4.27.

image of chemical structure

Exelon Patch is for transdermal administration. The patch comprises a four-layer laminate containing the backing layer, drug matrix, adhesive matrix and overlapping release liner. The release liner is removed and discarded prior to use. See Figure 1 for a detailed illustration.

image of Figure 1
Layer 1
Backing Film
Layer 2
Drug Product (Acrylic) Matrix
Layer 3
Adhesive (Silicone) Matrix
Layer 4
Release Liner (removed at time of use)
Excipients within the formulation include acrylic copolymer, poly(butylmethacrylate, methylmethacrylate), silicone adhesive applied to a flexible polymer backing film, silicone oil, and vitamin E.

Exelon Manufacturers

  • Physicians Total Care, Inc.
    Exelon (Rivastigmine) Patch, Extended Release [Physicians Total Care, Inc.]
  • Physicians Total Care, Inc.
    Exelon (Rivastigmine Tartrate) Capsule [Physicians Total Care, Inc.]
  • Rebel Distributors Corp
    Exelon (Rivastigmine) Patch, Extended Release [Rebel Distributors Corp]
  • Novartis Pharmaceuticals Corporation
    Exelon (Rivastigmine) Patch, Extended Release [Novartis Pharmaceuticals Corporation]
  • Novartis Pharmaceuticals Corporation
    Exelon (Rivastigmine Tartrate) Capsule Exelon (Rivastigmine Tartrate) Solution [Novartis Pharmaceuticals Corporation]

Login To Your Free Account